accepted and acknowledged
on 21 Sep 2022
Last Applicant/ Owned by
2-9 KANDA-TSUKASAMACHI,
CHIYODA-KU, TOKYO
JP
101-8535
Serial Number
86662242 filed on 15th Jun 2015
Registration Number
5052422 registered on 04th Oct 2016
Correspondent Address
Scott S. Havlick
Filing Basis
1. use application currently
Disclaimer
NO DATA
Pharmaceutical preparations and substances for the prevention and treatment of disorders and diseases in, generated by or acting on the central nervous system; pharmaceutical preparations and substances acting on the central nervous system; central nervous system stimulants; pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological disorders and di Read More
Pharmaceutical preparations and substances for the prevention and treatment of disorders and diseases in, generated by or acting on the central nervous system; pharmaceutical preparations and substances acting on the central nervous system; central nervous system stimulants; pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological disorders and diseases; pharmaceutical preparations and substances for the prevention and treatment of depression and schizophrenia; all of the foregoing containing brexpiprazole
10th Jul 2015
10th Jul 2015
No 86662242
No Service/Collective Mark
No 57182.0239
No
No
No
No
No
No
No
No
26.05.16 -
Triangles touching or intersecting
Status Date | Action Taken |
---|---|
21st Sep 2022 | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. |
21st Sep 2022 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
25th Mar 2022 | TEAS SECTION 8 & 15 RECEIVED |
04th Oct 2021 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
04th Oct 2016 | REGISTERED-PRINCIPAL REGISTER |
19th Jul 2016 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
19th Jul 2016 | PUBLISHED FOR OPPOSITION |
29th Jun 2016 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
09th Jun 2016 | APPROVED FOR PUB - PRINCIPAL REGISTER |
05th Mar 2016 | NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED |